What Health Systems Should Look for in a Specialty Pharmaceutical Distributor

Hospital procurement teams already manage more distributor relationships than most other parts of the health system, but specialty pharmaceutical sourcing raises the stakes further. Oncology drugs, biologics, and other high-cost therapies leave little room for a shipment delay or a documentation gap. While many of these relationships still run through familiar pharmacy wholesale suppliers for routine inventory, specialty categories call for a distributor evaluated on a different, more demanding set of criteria.

Why Health Systems Need More From Pharmacy Wholesale Suppliers on Specialty Lines

Hospital drug spending has been rising sharply. The American Hospital Association's 2026 Costs of Caring report found that hospital drug expenses increased 13.6 percent in 2025, with academic medical centers seeing a 21.6 percent jump over the same period, and drug costs now account for roughly 9 percent of total hospital expenses. Specialty and biologic products, which often carry list prices well into six figures, are a meaningful driver of that growth. A distributor that cannot document sourcing, storage, and chain-of-custody for these products with precision is not just an operational inconvenience. It is a direct financial and compliance exposure for the health system.

Hospital drug expenses rose 13.6 percent in 2025, with academic medical centers seeing a 21.6 percent increase, as drug spending grew to account for roughly 9 percent of total hospital costs. (Source: American Hospital Association, Costs of Caring 2026 report)

What "Specialty" Distribution Actually Requires

Specialty pharmaceutical distribution differs from routine generic wholesale in a few concrete ways that procurement teams should evaluate directly:

• Cold chain and temperature-controlled logistics — many specialty and biologic products require continuous temperature monitoring from warehouse to delivery, with documented proof at every stage

• Therapeutic category depth — oncology, immunology, and other specialty formulations need a distributor whose catalog and manufacturer relationships actually cover the categories a health system prescribes most

• Verified sourcing and traceability — DSCSA documentation, product verification, and chain-of-custody records need to hold up under both routine audit and urgent recall scenarios

• Responsive account support — specialty orders often involve time-sensitive coordination that a generic order desk is not built to handle

A Practical Example

Consider a health system opening a new outpatient infusion center that will require a steady supply of temperature-sensitive biologics. A distributor accustomed to serving general pharmacy wholesale suppliers' typical order patterns, built around routine generic volume, may not have the cold chain infrastructure or manufacturer relationships to support that launch reliably. A distributor with dedicated specialty capability, by contrast, can typically model expected order volume, confirm manufacturer allocation, and set up temperature-monitored delivery before the center opens its doors, rather than scrambling to source individual orders once patients are already scheduled.

Procurement Criteria That Matter Most

Beyond the categories above, health system procurement teams should weigh a distributor's licensing footprint, its ability to integrate with existing ERP or purchasing systems, and its track record supporting institutions of comparable size. A distributor licensed nationally, rather than in a handful of states, reduces the friction of expanding services or opening new facilities without renegotiating the sourcing relationship from scratch. Procurement teams should also confirm how a prospective partner handles multi-site institutions, since a health system with several hospitals or clinics under one purchasing umbrella needs consistent pricing, documentation, and service levels across every location, not a separate negotiation at each site.

Questions Procurement Teams Should Ask a Pharma Wholesaler

• Which specialty and therapeutic categories does your catalog actively cover, and how deep is manufacturer coverage in each?

• How do you document temperature control and chain-of-custody for cold chain products, and can that documentation be produced on request?

• What is your typical turnaround time for an urgent or time-sensitive specialty order?

• Are you licensed in every state where our facilities operate?

• What account support structure is in place specifically for hospital and health-system accounts, as distinct from independent pharmacy accounts?

Looking Past Unit Price

Given the sharp rise in specialty drug spending, it is tempting for procurement teams to negotiate primarily on unit price. Total cost of ownership tells a more complete story. A distributor with a lower unit price but inconsistent fill rates can force a health system into emergency sourcing at a premium, absorb pharmacy staff time on manual substitutions, and create documentation gaps that surface during an audit. Weighing service-level commitments, fill-rate history, and account responsiveness alongside price gives procurement teams a more accurate picture of what a specialty relationship will actually cost over a full contract term.

Where Drugzone Fits Into This Picture

Drugzone Pharmaceuticals Inc. is a nationally licensed pharmaceutical distributor supporting hospitals, long-term care facilities, and specialty pharmacies alongside independent pharmacy customers. Drugzone is licensed to distribute across all 50 U.S. states, is NABP-accredited and FDA-registered, and works toward DSCSA 2025 compliance and traceability across its supply chain. The company sources from a network of more than 75 manufacturers to support a catalog of more than 2,000 generic and specialty pharmaceutical SKUs, with product movement documented through a 20,000-square-foot temperature-controlled distribution facility. A dedicated team of more than 40 sales and account professionals supports institutional accounts through onboarding and ongoing procurement.

Health system procurement teams evaluating specialty distribution partners can speak with a distribution specialist to review catalog coverage, compliance documentation, and account structure before their next contract cycle.

Frequently Asked Questions

1. How Is Specialty Pharmaceutical Distribution Different From Working With Routine Pharmacy Wholesale Suppliers?

Specialty distribution involves higher-cost, often temperature-sensitive products that require deeper documentation, cold chain logistics, and faster turnaround for urgent orders. Routine generic wholesale relationships are typically built around volume and catalog breadth rather than these specialized requirements.

2. What Documentation Should a Health System Require for Cold Chain Products?

Ask for documented temperature monitoring records covering the full path from warehouse to delivery, along with chain-of-custody documentation that supports both routine audits and any recall scenario.

3. Why Does DSCSA Compliance Matter More for Specialty Products?

Specialty and biologic products often carry significant per-unit cost and elevated diversion risk, which makes accurate, package-level traceability especially important for both patient safety and financial accountability.

4. Should a Health System Use the Same Distributor for Routine and Specialty Needs?

Many health systems do, provided the distributor can demonstrate the deeper documentation, cold chain capability, and account support that specialty categories require. Others maintain a separate specialty relationship where catalog depth or turnaround time makes that the better fit.

5. What Should Procurement Teams Ask About Account Support Before Signing?

Ask specifically how the distributor structures support for hospital and health-system accounts, since institutional purchasing patterns, urgent order handling, and compliance documentation needs differ meaningfully from independent pharmacy accounts.